The Clorox Company (NYSE:CLX) Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. increased its stake in The Clorox Company (NYSE:CLX - Free Report) by 21.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,508 shares of the company's stock after buying an additional 3,249 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Clorox were worth $3,013,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CLX. Mizuho Securities USA LLC raised its position in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP lifted its stake in shares of Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock worth $88,315,000 after acquiring an additional 453,624 shares during the last quarter. International Assets Investment Management LLC grew its position in Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company's stock valued at $877,390,000 after acquiring an additional 435,971 shares during the last quarter. Boston Trust Walden Corp increased its stake in Clorox by 5,442.5% in the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company's stock worth $44,622,000 after purchasing an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. lifted its position in shares of Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock worth $57,390,000 after purchasing an additional 265,455 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Stock Up 1.4 %

CLX traded up $2.12 on Thursday, hitting $150.77. The company had a trading volume of 1,146,565 shares, compared to its average volume of 1,334,095. The stock has a market capitalization of $18.66 billion, a price-to-earnings ratio of 41.19, a P/E/G ratio of 2.52 and a beta of 0.42. The stock has a fifty day moving average price of $159.93 and a 200-day moving average price of $159.19. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company posted $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.24%. Clorox's dividend payout ratio (DPR) is 133.33%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on CLX shares. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reissued a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox has a consensus rating of "Hold" and an average price target of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.